What Are the Side Effects of Repatha?

What side effects does Mayo Clinic list for Repatha?

Mayo Clinic lists body aches or pain, chills, muscle aches, and a general feeling of discomfort or illness among effects labeled “more common.” It also lists back pain and injection-site effects, while muscle or joint pain, muscle stiffness, and swollen joints appear among effects described as less common or worth discussing if persistent or bothersome.

Those labels sort reported effects; they do not establish that evolocumab caused a particular person’s symptom. Timing, other health conditions, and other medicines are part of the clinical picture. A symptom list can help frame a discussion, not settle its cause.

The U.S. Food and Drug Administration’s 2024 Repatha prescribing information reports influenza and back pain among adverse reactions occurring in more than 5% of treated adults with primary hyperlipidemia and more frequently than with placebo. The FDA label also reports local injection-site reactions in 3.2% of Repatha-treated patients and 3.0% of placebo patients. These are trial results, not a forecast for any one person; DailyMed cautions that trial rates may not reflect clinical practice and cannot be directly compared across different drugs.

Can Repatha cause muscle or joint pain, back pain, or flu-like symptoms?

Mayo Clinic lists muscle aches and a general feeling of illness among more common effects, and muscle or joint pain, stiffness, and swollen joints among less common effects to discuss if they persist or bother you. Its listing of symptoms does not prove that Repatha caused a specific ache or flu-like feeling.

The FDA label includes influenza and back pain among reactions reported more often with Repatha than placebo in the specified adult trials. “Flu-like symptoms” can describe a person’s experience, but that phrase alone cannot tell whether the symptom is influenza, another illness, or a reaction to treatment. A clinician can weigh the pattern and context.

For a useful conversation, keep a short record: the symptom, when it began, whether it followed an injection, how long it lasted, and whether it is changing. Note other new medicines or health changes as well. Ask whether the timing fits a known effect, whether another cause needs checking, and what changes would warrant prompt contact.

Mayo Clinic advises contacting a healthcare professional if side effects continue, are bothersome, or raise questions. Do not change or stop treatment without medical guidance; the prescriber can help weigh symptoms against the reason Repatha was prescribed.

Are injection-site redness, swelling, or itching normal with Repatha?

Redness, swelling, itching, pain, tenderness, warmth, and bruising-like skin changes are among the injection-site effects Mayo Clinic lists. These are recognized local reactions, but a list does not determine whether a particular skin change is expected or needs assessment.

The FDA’s 2024 prescribing information says local injection-site reactions occurred in 3.2% of Repatha-treated patients and 3.0% of placebo patients in pooled controlled trials; redness, pain, and bruising were the most common local reactions. The label reports that 0.1% of treated patients discontinued because of local injection-site reactions. These study figures describe trial groups and do not predict an individual’s experience.

Mayo Clinic’s evolocumab information advises rotating injection areas and avoiding skin that is bruised, hard, red, or tender. Note where each injection was given and what the skin looked and felt like afterward. If a reaction continues, worsens, or concerns you, contact the prescribing clinician rather than deciding on your own to alter treatment.

Which Repatha side effects require urgent medical attention?

Difficulty breathing or swallowing, hives or rash, and hive-like swelling of the face, lips, tongue, throat, or other areas can indicate a serious allergic reaction; Mayo Clinic advises prompt medical attention for these warning signs. Treat breathing or throat symptoms as urgent and seek immediate help.

The FDA’s 2024 prescribing information says hypersensitivity reactions, including angioedema, have been reported with Repatha. It directs discontinuation and appropriate treatment if serious hypersensitivity signs or symptoms occur. The product is contraindicated for people with a history of serious hypersensitivity to evolocumab or its ingredients, according to the DailyMed prescribing information.

People sensitive to latex can also ask about the device: the FDA label says certain prefilled syringe and autoinjector needle covers contain dry natural rubber, a latex derivative, and advises considering a latex-free presentation. Ask a pharmacist or prescriber to identify the presentation supplied if latex sensitivity is relevant.

For non-urgent but persistent symptoms, contact the prescribing clinician and give a clear timeline. A brief log of symptoms, injection dates and sites, and any related changes can make the discussion more specific. Do not stop or change Repatha on your own for ordinary aches, fatigue, or a local reaction; ask the clinician how to proceed.